Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.-论文-万方医学网

第一作者： Katherine C,Fuh

第一单位： Division of Gynecologic Oncology, Helen Diller Family Comprehensive Cancer Center, University Of California, San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1702, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, School of Medicine, St. Louis, MO 63108, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University, School of Medicine, 400 Pasteur Drive, Stanford, CA 94305, United States.

作者： Katherine C,Fuh ^[1] ; Angeles A,Secord ^[2] ; Kerri S,Bevis ^[3] ; Warner,Huh ^[3] ; Adam,ElNaggar ^[4] ; Kevin,Blansit ^[5] ; Rebecca,Previs ^[2] ; Todd,Tillmanns ^[4] ; Daniel S,Kapp ^[6] ; John K,Chan ^[7]

作者单位： Division of Gynecologic Oncology, Helen Diller Family Comprehensive Cancer Center, University Of California, San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1702, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, School of Medicine, St. Louis, MO 63108, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University, School of Medicine, 400 Pasteur Drive, Stanford, CA 94305, United States. ^[1] Division of Gynecologic Oncology, Department Of Obstetrics and Gynecology, Duke University, School Of Medicine, DUMC 3079, Durham, NC 27710, United States. ^[2] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 1700 6th Ave South, Birmingham, AL 35233, United States. ^[3] The West Clinic, University of Tennessee, 100N. Humphreys Blvd, Memphis, TN 38120, United States. ^[4] Division of Gynecologic Oncology, Helen Diller Family Comprehensive Cancer Center, University Of California, San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1702, United States; Palo Alto Medical Foundation Research Institute, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, United States. ^[5] Department of Radiation Oncology, Department of Obstetrics and Gynecology, Stanford University, School of Medicine, 400 Pasteur Drive, Stanford, CA 94305, United States. ^[6] Division of Gynecologic Oncology, Helen Diller Family Comprehensive Cancer Center, University Of California, San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1702, United States; Palo Alto Medical Foundation Research Institute, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, United States. Electronic address: chanjohn@sutterhealth.org. ^[7]

医学主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);输卵管肿瘤(Fallopian Tube Neoplasms);女(雌)性(Female);人类(Humans);淋巴转移(Lymphatic Metastasis);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);卵巢肿瘤(Ovarian Neoplasms);腹膜肿瘤(Peritoneal Neoplasms);聚乙烯二醇类(Polyethylene Glycols);放射摄影术(Radiography);回顾性研究(Retrospective Studies);存活率(Survival Rate);紫杉烷类(Taxoids);托泊替坎(Topotecan);青年人(Young Adult)

DOI 10.1016/j.ygyno.2015.06.041

PMID 26144600

发布时间 2022-12-07

检索历史清除

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.

Gynecologic oncology

相似文献

同项目论文

Gynecologic oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.

Gynecologic oncology

相似文献

同项目论文

Gynecologic oncology

相关期刊

检索历史清除